Associate Professor at Institute of Forestry under the Tribhuvan University, Dr Lalit Kumar Das, who has claimed that he developed medicine against coronavirus has forwarded the testing process through the Social Development Ministry of Bagmati State.
Dr Das began the official and legal process for the medicine trial with the coordination of Social Development Minister of Bagmati State, Yubraj Dulal. Minister Dulal had held discussion with the experts from the State and scientists from across the country on Friday itself. Following the discussion, Minister Dulal shared the information that decision was made for the official trail of the medicine.
“Now, the tests of medicine developed by Dr Das would be forwarded through the Nepal Health Research Council,” said Minister Dulal, adding that State government and federal government will fully cooperate with it.
Dr Das has claimed that he developed nine types of medicines having both curative and preventive elements against the coronavirus. Among them, six medicines could be used as vaccination to prevent the disease and three others as curative.
He further argued that he studied the coronavirus and its chemical and other features and it could be rendered dysfunctional with the use of 15 types of plants. The medicine also dissipates and makes dysfunctional fat and protein of the coronavirus. Although the virus is not tested in laboratory, scientific test was conducted. Scientist Dr Das further said the medicine is made out of the plants the human has been using for long and it would have no side effects. But, some may develop minor allergy, he added.
RSS News Impact
The National News Agency (RSS) had first made the story on Dr Das’ research in Nepal, which gained huge publicity, earning accolade to him. Das who earned PhD in chemistry from Banarash University, India, is the Associate Professor at Hetauda Campus under the Institute of Forestry, TU. Permanent resident of Kalaiya, Bara district, Das has been teaching for over two decades.
WHO suggest Dr Das to develop medicine as syrup as well
Meanwhile, the World Health Organization (WHO) has suggested Dr Das to develop the medicine in syrup too. Dr Das has so far prepared it for the use as vaccination. The WHO has given 16-page long suggestions along with some queries to researcher Das. He added that suggestion was given in email after the talk via videoconference.
His research assistant and botanist at the Institute, Damodar Gaire, said the WHO suggested for syrup, reasoning some could see allergy with vaccination. Gaire added that WHO made positive response after it was informed of the composition of the medicine. “WHO has even asked us how much we can provide if needed,” he added.
Source: National News Agency
